ROCHE HLDG DR (RHO5 HM) stock market data APIs
€302.3656
4.75(1.6%)
as of October 20, 2025
Try our APIs with
free plan!
ROCHE HLDG DR Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for RHO5.HM.
Prev. Close
302.3656
Open
307.1172
High
307.1172
Low
297.9415
52 wk Range
235.4067-314.8
Market Cap
312 681 M
Dividends (Yield)
0.0415
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ROCHE HLDG DR data using free add-ons & libraries
Get ROCHE HLDG DR Fundamental Data
ROCHE HLDG DR Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ROCHE HLDG DR News
New
AstraZeneca's Cancer Breakthrough: Enhertu Data Sparks New Hope for Early Breast Cancer Cure
This article first appeared on GuruFocus. AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo just delivered one of the most consequential oncology updates of the year. Their breast cancer therapy, Enhertu, ...
Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results
Celcuity stock shot to a record high Monday after the company said its experimental drug delayed breast cancer progression for over a year. Continue Reading View comments
Olema Pharmaceuticals Shares Fall After Roche's Breast Cancer Data Weighs on Sector
Olema Pharmaceuticals (OLMA) shares fell 14% in Monday trading even after encouraging results for it PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor
IMPALA PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
